glp 1 agonist stands for Everyone is talking about GLPs. But do you know the difference between them? Semaglutide. Tirzepatide. Retatrutide. Three different medications. Three different mechanisms. And one thing they all have in common: they Nutritional priorities to support GLP-1
Description
Both cause similar side effects, primarily gastrointestinal issues like nausea, diarrhea, and constipation
CONTRAINDICATIONS History of hypersensitivity reaction to tirzepatide or any of its excipients Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) PRECAUTIONS Kidney disease No dose adjustment is recommended in patients with any degree of renal impairment Liver disease No dose adjustment is recommended in patients with any degree of liver disease Stomach disorders Tirzepatide slows gastric emptying and is not recommended in patients with significant stomach disorders, including diabetic gastroparesis General anesthesia or deep sedation GLP-1 therapies, like tirzepatide, slow gastric emptying, possibly increasing the risk of residual gastric contents and pulmonary aspiration in patients receiving anesthesia or deep sedation for procedures
In clinical trials with participants with obesity, 5 mg, 10 mg, or 15 mg of tirzepatide once weekly provided substantial and sustained reductions in body weight over 72 weeks [22]
The same drug, prescribed for diabetes, is treated as medically necessary and reimbursable
